ECSP088237A - Derivados de quinolina y uso como agentes antitumor - Google Patents
Derivados de quinolina y uso como agentes antitumorInfo
- Publication number
- ECSP088237A ECSP088237A EC2008008237A ECSP088237A ECSP088237A EC SP088237 A ECSP088237 A EC SP088237A EC 2008008237 A EC2008008237 A EC 2008008237A EC SP088237 A ECSP088237 A EC SP088237A EC SP088237 A ECSP088237 A EC SP088237A
- Authority
- EC
- Ecuador
- Prior art keywords
- formula
- antitumor agents
- quinolina
- derivatives
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
- Quinoline Compounds (AREA)
Abstract
La invención provee compuestos de formula I descritos aquí, en donde Y es F, Cl o Br, o una sal farmacéuticamente aceptable de los mismos. Los compuestos son agentes antitumor efectivos. La invención provee también composiciones farmacéuticas que comprenden un compuesto de formula I o una sal del mismo, intermediarios útiles para preparar un compuesto de formula I, y métodos terapéuticos que comprenden administrar un compuesto de formula I o una sal del mismo a un mamífero en necesidad del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/223,806 US7470788B2 (en) | 2005-09-07 | 2005-09-09 | Antitumor agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP088237A true ECSP088237A (es) | 2008-07-30 |
Family
ID=37708463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2008008237A ECSP088237A (es) | 2005-09-09 | 2008-03-04 | Derivados de quinolina y uso como agentes antitumor |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7470788B2 (es) |
| EP (1) | EP1940794A2 (es) |
| JP (1) | JP2009507858A (es) |
| KR (1) | KR20080059185A (es) |
| CN (1) | CN101258129A (es) |
| AU (1) | AU2006287275A1 (es) |
| BR (1) | BRPI0615583A2 (es) |
| CA (1) | CA2621988C (es) |
| CR (1) | CR9858A (es) |
| EA (1) | EA200800776A1 (es) |
| EC (1) | ECSP088237A (es) |
| IL (1) | IL189819A0 (es) |
| MA (1) | MA30299B1 (es) |
| NO (1) | NO20081736L (es) |
| TN (1) | TNSN08093A1 (es) |
| WO (1) | WO2007030780A2 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE287397T1 (de) * | 2001-07-31 | 2005-02-15 | Univ Wayne State | Chinoline derivate und ihre anwendung als antitumor agentien |
| US7470788B2 (en) | 2005-09-07 | 2008-12-30 | Wayne State University | Antitumor agents |
| US8183379B2 (en) * | 2005-09-07 | 2012-05-22 | Wayne State University | Antitumor agents |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6033389B2 (ja) | 1979-02-22 | 1985-08-02 | 日産化学工業株式会社 | 複素環エ−テル系フェノシキ脂肪酸誘導体、その製造法および該誘導体を含有する除草剤 |
| ATE287397T1 (de) * | 2001-07-31 | 2005-02-15 | Univ Wayne State | Chinoline derivate und ihre anwendung als antitumor agentien |
| UA79293C2 (en) | 2002-07-03 | 2007-06-11 | Univ Wayne State | 4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents |
| US7470788B2 (en) | 2005-09-07 | 2008-12-30 | Wayne State University | Antitumor agents |
| US20070054938A1 (en) | 2005-09-07 | 2007-03-08 | Horwitz Jerome P | Antitumor agents |
-
2005
- 2005-09-09 US US11/223,806 patent/US7470788B2/en not_active Expired - Fee Related
-
2006
- 2006-09-11 BR BRPI0615583A patent/BRPI0615583A2/pt not_active IP Right Cessation
- 2006-09-11 EP EP06814396A patent/EP1940794A2/en not_active Withdrawn
- 2006-09-11 WO PCT/US2006/035184 patent/WO2007030780A2/en active Application Filing
- 2006-09-11 EA EA200800776A patent/EA200800776A1/ru unknown
- 2006-09-11 CA CA2621988A patent/CA2621988C/en not_active Expired - Fee Related
- 2006-09-11 JP JP2008530249A patent/JP2009507858A/ja not_active Withdrawn
- 2006-09-11 AU AU2006287275A patent/AU2006287275A1/en not_active Abandoned
- 2006-09-11 KR KR1020087008480A patent/KR20080059185A/ko not_active Application Discontinuation
- 2006-09-11 CN CNA2006800329027A patent/CN101258129A/zh active Pending
-
2008
- 2008-02-28 TN TNP2008000093A patent/TNSN08093A1/en unknown
- 2008-02-28 IL IL189819A patent/IL189819A0/en unknown
- 2008-03-04 EC EC2008008237A patent/ECSP088237A/es unknown
- 2008-04-01 MA MA30804A patent/MA30299B1/fr unknown
- 2008-04-02 CR CR9858A patent/CR9858A/es not_active Application Discontinuation
- 2008-04-08 NO NO20081736A patent/NO20081736L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007030780A3 (en) | 2007-09-13 |
| CR9858A (es) | 2008-08-11 |
| NO20081736L (no) | 2008-06-06 |
| MA30299B1 (fr) | 2009-04-01 |
| AU2006287275A1 (en) | 2007-03-15 |
| EP1940794A2 (en) | 2008-07-09 |
| WO2007030780A2 (en) | 2007-03-15 |
| CA2621988C (en) | 2014-03-25 |
| JP2009507858A (ja) | 2009-02-26 |
| IL189819A0 (en) | 2008-11-03 |
| CA2621988A1 (en) | 2007-03-15 |
| TNSN08093A1 (en) | 2009-07-14 |
| US20070060612A1 (en) | 2007-03-15 |
| KR20080059185A (ko) | 2008-06-26 |
| US7470788B2 (en) | 2008-12-30 |
| CN101258129A (zh) | 2008-09-03 |
| BRPI0615583A2 (pt) | 2016-11-16 |
| EA200800776A1 (ru) | 2008-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY29087A1 (es) | Derivados de adamantilo, composiciones farmaceuticas que los contienen, procesos para su preparacion y uso terapeutico | |
| CO6470847A2 (es) | Derivados amino-propiónicos sustituidos como inhibidores de neprilisina | |
| ECSP088871A (es) | Derivados de triazolopirazina | |
| CU20110216A7 (es) | Derivados aminobutíricos sustituidos como inhibidores de neprilisina | |
| GT200600163A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
| AR072442A1 (es) | Metodo para la terapia del cancer, uso, kit | |
| PA8591701A1 (es) | Derivados de pirrolopirimidina | |
| UY30819A1 (es) | Derivados de pirazol, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones | |
| SV2008002969A (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
| EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
| DOP2006000170A (es) | Nuevos derivados de espirocromanona | |
| ECSP088973A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
| AR048336A1 (es) | Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
| AR083879A1 (es) | Analogos de aminoglicosidos antibacterianos, metodos de preparacion y uso como agentes terapeuticos | |
| UY29370A1 (es) | Derivados de tiazol, composiciones que lo contienen, procedimientos de preparación y aplicaciones | |
| AR067770A1 (es) | Derivados de tiazol y ditiazol para el tratamiento de diabetes | |
| UY28979A1 (es) | Derivados de hidrocloruros de 3-carboxamida, composiciones farmacéuticas que los contienen, procedimiento de preparación y su uso, útiles como inhibidores selectivos de gsk3 | |
| CR11208A (es) | Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas | |
| UY30847A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales | |
| UY33745A (es) | Derivados de difenilamina: usos, procedimiento de síntesis y composiciones farmacéuticas | |
| ECSP088237A (es) | Derivados de quinolina y uso como agentes antitumor | |
| AR077884A1 (es) | (4-(5-aminometil- fenil)-piperidin-1-il)-1h-indol-3-il)-metanonas disustituidas | |
| PT1412332E (pt) | Derivados de quinolina e sua utilizacao como agentes antitumorais | |
| AR059612A1 (es) | Compuestos de piperidinil piperazina antagonistas de receptores ccr5. | |
| UY28387A1 (es) | Compuestos novedosos |